Blog

UW General Surgery Resident Explains T Cell Immunotherapy in Fibrolamellar Carcinoma – Rare Disease Report

UW General Surgery Resident Explains T Cell Immunotherapy in Fibrolamellar Carcinoma
Rare Disease Report
Kevin Sullivan, M.D., is a General Surgery Resident at the University of Washington, and is taking time off from his residency to act as a fellow for the Fibrolamellar Cancer Foundation (FCF). As the principal investigator in a study of T cell

2017-12-07 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.